Halozyme Therapeutics HALO Deferred Rent Payments
Deferred Rent Payments at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept halo:DeferredRentPayments.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's deferred rent payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's deferred rent payments?
- Halozyme Therapeutics (HALO) reported deferred rent payments of -$214K in Q1 2026.
- How has Halozyme Therapeutics's deferred rent payments changed year-over-year?
- Halozyme Therapeutics's deferred rent payments increased by 15.4% year-over-year, from -$253K to -$214K.
- What is the long-term trend for Halozyme Therapeutics's deferred rent payments?
- Over 4 years (2021 to 2025), Halozyme Therapeutics's deferred rent payments has grown at a 6.1% compound annual growth rate (CAGR), from $751K to -$951K.
- What does deferred rent payments mean?
- Non-cash adjustment for the timing difference between rent expense and cash rent paid.
- How do you interpret deferred rent payments?
- A consistent trend indicates the company's long-term real estate commitment and lease structure.
- How does deferred rent payments compare across companies?
- Comparable across companies with significant office or facility lease footprints.